NCT00637832 2022-01-06Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin LymphomaUniversity of SouthamptonPhase 2 Terminated1 enrolled